21

Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Embed Size (px)

Citation preview

Page 1: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4
Page 2: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Pancreatic CancerPancreatic Cancer

L. OkolicsanyiG. Morana

Page 3: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Pancreas CancerPancreas Cancer

2nd most common GI malignancy 30,000 cases per year in US 25,000 deaths per year 4th leading cause of death in both men and

women Incidence slowly rising M>F (1.3:1) Rare before 45 yrs

Page 4: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Pancreas CancerPancreas Cancer EtiologyEtiology Diabetes mellitus Diet: Nitrosamines, Animal fat Cigarettes Hereditary predisposition (Hereditary

pancreatitis) Family cancer syndromes (e.g., Peutz-

Jeghers, Von Hippel-Lindau, Gardner’s) Benign disease: Chronic pancreatitis,

Intraductal papillary mucinous neoplasms

Page 5: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4
Page 6: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Normal Pancreas

Page 7: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Pancreatic TumorsPancreatic Tumors

Epithelial– Ductal epithelium (adenocarcinoma and others)– Cystic neoplasms, serous or mucinous

Endocrine– Islet cell tumors, carcinoid tumors

Exocrine– Acinar cell carcinoma

Mesenchymal-Rare

Page 8: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4
Page 9: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4
Page 10: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Risk Factors for Pancreatic Risk Factors for Pancreatic CancerCancer

Page 11: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Gene Pancreatic Cancer

(%)

Colorectal Cancer

(%)

p16 95 0

K-ras 90 50

p53 75 60

DPC4 55 15

BRCA2 7 ?

Relevance of Genetic Mutations in Pancreatic CancerRelevance of Genetic Mutations in Pancreatic Cancer

Page 12: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Pancreas CancerPancreas CancerClinical FeaturesClinical Features Weight loss Head:

– Painless jaundice– Gastric outlet obstruction

Body & Tail– Pain– Diabetes mellitus without family history

Metastasis: Hepatomegaly, ascites, Virchow’s (left supraclavicular) node, Trousseau’s syndrome (migratory superficial thrombophlebitis)

Page 13: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4
Page 14: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Pancreas CancerPancreas CancerCourvoisier’s lawCourvoisier’s law

“In the presence of jaundice a palpable gall bladder is unlikely to be due to stone”

Page 15: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Pancreas CancerPancreas CancerInvestigationsInvestigations Laboratory tests:

– LFT’s– CA 19-9

Radiologic tests:– Ultrasound– CT scan + biopsy– ERCP + biopsy– EUS + biopsy

Page 16: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Algorithm for diagnosis and staging of Pancreatic CancerAlgorithm for diagnosis and staging of Pancreatic Cancer

FNAC

Page 17: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Pancreas CancerPancreas CancerTreatmentTreatment Curative:

– Resection if possible– Unresectable if metastasis or major vessel

involvement– Whipple procedure for head (radical

pancreatoduodenectomy)– Distal pancreatectomy for body & tail

Palliative:– Bypass– Stent

Page 18: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4
Page 19: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Actuarial Survival after Actuarial Survival after Pancreatico- duodenectomyPancreatico- duodenectomy

Page 20: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Pancreas CancerPancreas CancerSurvival at 5 yrsSurvival at 5 yrs

Head of Pancreas 5-15% Body & Tail of pancreas 2% Distal CBD 15-35% Ampulla 30-65%

Mild improvement with adjuvant therapy

Page 21: Pancreatic Cancer L. Okolicsanyi G. Morana Pancreas Cancer l 2nd most common GI malignancy l 30,000 cases per year in US l 25,000 deaths per year l 4

Pancreas CancerPancreas Cancer